Hourly refreshThu, Oct 15, 2026

Press Release Database

Recent press releases, indexed by topic.
AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
Results
Showing all · 117004 itemsDownloadExcelTXT
In the wire

Scientology Network zeigt Dokumentarfilm über Grammy-Preisträger Mark Isham

(PR-inside.com) Das Scientology Network präsentiert im Oktober die Premiere der Dokumentation "Mark Isham: The Voice Within" aus der Reihe "Signature Performances". Der Film begleitet den Grammy- und Emmy-Preisträger bei der Produktion seines neuen Albums "At the Carousel Club", seiner ersten Neuveröffentlichung seit 15 Jahren. In den Mad Hatter Studios, in denen bereits Künstler wie Paul McCartney und Prince aufnahmen, gewährt Isham Einblicke in den Entstehungsprozess seines Albums. Der Trompeter und Komponist verbindet dabei elektronische Klänge mit den Darbietungen erfahrener Musiker. Die Dokumentation zeigt Studioaufnahmen, kreative Entscheidungen und die Herausforderungen während der Produktion. An den Aufnahmen wirken unter anderem Schlagzeuger Vinnie Colaiuta, Sängerin Ayo ..

Oct 15 · 14:31PR-Inside
Healthcare · Automotive

Neuroendocrine Prostate Cancer Market to Witness Growth at a 25% CAGR by 2036 Due to the Emergence of Emerging agents, including DLL3-targeted Therapies, ADCs, BsAbs, CAR-Ts, Aurora Kinase Inhibitors, and EZH2 Inhibitors | DelveInsight

The neuroendocrine prostate cancer market is expected to grow steadily, driven by the rising recognition of NEPC as an aggressive and treatment-resistant form of prostate cancer. Additionally, the ongoing clinical development of investigational therapies such as Peluntamig (PT217; Phanes...

Oct 15 · 14:31PR Newswire
Finance

Securities Lawsuit Alert: Unicycive Therapeutics, Inc. (UNCY) - Contact ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 15, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Unicycive Therapeutics, Inc. (NASDAQ:UNCY) securities. If you suffered a loss on your Unicycive Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Unicycive Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..

Oct 15 · 14:30PR-Inside
Finance

Levi & Korsinsky Urges The Chemours Company (CC) Shareholders to Act ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 15, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired The Chemours Company (NYSE:CC) securities. If you suffered a loss on your The Chemours Company investment and would like to explore a potential recovery under the federal securities laws, Learn about The Chemours Company Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..

Oct 15 · 14:30PR-Inside
Finance

Lost Money on Baidu, Inc. (BIDU)? Contact Levi & Korsinsky Before November ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 15, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Baidu, Inc. (NASDAQ:BIDU) securities. If you suffered a loss on your Baidu, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Baidu, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Baidu, Inc. ..

Oct 15 · 14:30PR-Inside
Finance

ARDX ALERT: Securities Fraud Class Action Launched Against Ardelyx, ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 15, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Ardelyx, Inc. (NASDAQ:ARDX) securities. If you suffered a loss on your Ardelyx, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Ardelyx, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Ardelyx, Inc. ..

Oct 15 · 14:25PR-Inside
Finance

Join Class Action to Recover Losses from AST SpaceMobile, Inc. (ASTS) ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 15, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired AST SpaceMobile, Inc. (NASDAQ:ASTS) securities. If you suffered a loss on your AST SpaceMobile, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about AST SpaceMobile, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..

Oct 15 · 14:25PR-Inside
Finance

Join Class Action to Recover Losses from Doximity, Inc. (DOCS) - Contact ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 15, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Doximity, Inc. (NYSE:DOCS) securities. If you suffered a loss on your Doximity, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Doximity, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Doximity, Inc. ..

Oct 15 · 14:25PR-Inside
In the wire

Physician, Air Force Veteran and Best-Selling Author Dr. Remina Panjwani Launches Dr. Remina's DEPLOYMENT METHOD™ - Fewer Americans Call Their Workplace Healthy

The board-certified physician, who deployed to Baghdad and worked as a hospitalist on the COVID front line, introduces a three-phase framework that treats burnout as a system problem, not a personal weakness. The launch comes as she returns with a new season of The Dr. Remina Panjwani...

Oct 15 · 14:25PRWeb
SaaS

FARFETCH presents the Holiday Campaign

FARFETCH, the global platform for luxury, reveals its 2026 Holiday Campaign, celebrating the season through the lens of Marili Andre and Sharna Osborne. The seasonal campaign spotlights women's and men's curated edits that serve as the ultimate inspiration for festive partywear, luxury gifting, and holiday getaways. - - Statement Partywear & Timeless Gifts - - The campaign features a series of curated edits of most-wanted gifts for her and for him, thoughtfully categorised across small... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=362899

Oct 15 · 14:20WebWire
Healthcare

BioInvent Announces Publication of First-in-Human BI-1808 Data in Clinical ...

(PR-inside.com) BI-1808 monotherapy demonstrated an excellent safety profile and evidence of single-agent anti-tumor activity, correlating with tumor-infiltrating CD8+ T cells and inducing antitumor immunity. Translational data were consistent with BI-1808's preclinically characterized mechanism of action, which includes regulatory T cell depletion, myeloid reprogramming, tertiary lymphoid structure formation, and activation of T cell anti-tumor immunity. Phase 1 dose escalation in 24 patients with advanced solid tumors did not identify a maximum tolerated dose, with no dose-limiting toxicities and no deaths. All treatment-related AEs were limited to Grades 1 or 2. Durable partial response throughout the study duration (two years) in a GIST patient, a ..

Oct 15 · 14:20PR-Inside
In the wire

Chandra Finds Possible Origin of ‘Treble Clef’ Waves

A formation of radio waves looks remarkably like a treble clef in this Oct. 14, 2026, image from NASA’s Chandra X-Ray Observatory. Researchers used Chandra to find that the Treble Clef is likely caused by an outburst from a supermassive black hole, followed by a collision of two galaxy clusters. Read more about this discovery. […]

Oct 15 · 14:19NASA
← Prev123…9751Next →